Personalized Cancer Treatment Guidance

Treatment guidance informed by tumor genetics and biomarkers.
Understand how your tumor profile can guide treatment decisions, including targeted therapy, immunotherapy, and clinical trials

Licensed in CA, CO, CT, DC, DE, FL, HI, MA, MD, NC, NH, NJ, NV, NY, OK, PA, TX, VA, WA, and WV

Request a Consultation

About Personalized Cancer Medicine

Not every cancer responds the same way to treatment. While many tumors are tested for biomarkers and molecular features, patients and care teams don’t always receive clear guidance on what those results mean for treatment decisions.

At EPIARX, we interpret your pathology, molecular testing, and clinical context to provide clear, actionable insight into your treatment options.

Our goal is to help you and your oncologist answer:

  • Does this tumor have a targetable mutation?

  • Do current findings support immunotherapy?

  • Are there additional or alternative treatment options to consider?

  • Are there gaps in testing that should be addressed first?

What This Service Includes

Personalized Cancer Medicine Consultation

Discuss your diagnosis and explore treatment options based on your tumor’s molecular profile.

Depending on your case, this may include:

  • Expert review of pathology and molecular testing results

  • Interpretation of key biomarkers (e.g., HER2, ER/PR, PD-L1, KRAS, EGFR, ALK, BRAF, MSI)

  • Alignment of findings with current or potential treatment strategies

  • Recommendations for additional or reflex testing, if needed

  • A clear, therapy-focused summary you can share with your oncologist

Why Choose Personalized Cancer Medicine at EPIARX?

  1. Pathology and treatment insight in one place
    Led by a board-certified pathologist with deep expertise in cancer diagnostics and biomarker interpretation

  2. From findings to decisions
    We go beyond listing mutations—translating results into clinically meaningful treatment insights

  3. Identify missed opportunities
    Uncover additional biomarkers or testing strategies that may expand treatment options

  4. Fast, virtual access
    Meet online to review results quickly, so you don’t lose time in treatment planning

  5. Clear, shareable reporting
    Receive organized, therapy-relevant insights you can bring to your care team

Our Process

Ideal Candidates

  • Patients recently diagnosed with cancer who have received molecular or biomarker testing

  • Patients seeking clarity on targeted therapy or immunotherapy options

  • Cases with complex, borderline, or unusual biomarker findings

  • Patients exploring whether additional testing may open new treatment paths

  • Families seeking a second perspective on how treatment aligns with tumor biology

Some Commonly Asked Questions

Do I need to repeat my biopsy?
Not always. Many patients can use existing slides/reports. We will tell you if further testing would be beneficial.

What if I don’t have molecular testing yet?
We can review your current pathology and recommend which tests are most relevant for your tumor type.

Will you tell me what treatment to take?
We will explain which therapies are supported by your results and which additional tests may expand options. Final treatment decisions are made by your treating oncologist.

Can this help with clinical trials?
Yes — understanding your tumor’s molecular profile helps your team identify trials you may qualify for.

Request a Consultation

Turn complex test results into clear treatment direction